Cyclovirobuxine D - Bio-X ™

CAS : 860-79-7

Ref. 3D-BC300058

Informations sur le produit

• Nom: Cyclovirobuxine D - Bio-X ™
• Synonymes: (3beta,5alpha,9beta,16alpha,20S)-4,4,14-trimethyl-3,20-bis(methylamino)-9,19-cyclopregnan-16-ol, (3beta,5alpha,9xi,10xi,14xi,16alpha,20S)-4,4,14-trimethyl-3,20-bis(methylamino)-9,19-cyclopregnan-16-ol, (3α,5α,16α,20S)-4,4,14-Trimethyl-3,20-bis(methylamino)-9,19-cyclopregnan-16-ol, (3β,5α,16α,20S)-4,4,14-Trimethyl-3,20-bis(methylamino)-9,19-cyclopregnan-16-ol, 1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene, 9,19-cyclopregnan-16-ol deriv., 9,19-Cyclo-5α,9β-pregnan-16α-ol, 4,4,14-trimethyl-3β,20α-bis(methylamino)-, 9,19-Cyclopregnan-16-ol, 4,4,14-trimethyl-3,20-bis(methylamino)-, (3β,5α,16α,20S)-, Bebuxine, Cvb-D, Cyclovirobuxin D, Cyclovirobuxine, Cyclovirobuxinum D, NSC 91722

Description

Cyclovirobuxine D is a steroidal alkaloid component derived from the root of the medicinal plant Buxus microphylla that has been shown to benefit in treating heart failure, arrhythmias, myocardial ischemia, and other cardiovascular illnesses. It is believed to boost Ca (2+) release and absorption during systolic and diastolic phases. Cyclovirobuxine D has also been shown to have a synergistic effect with cyclase inhibitors, such as rolipram and rolofylline, in the prevention of myocardial infarct.

Cyclovirobuxine D is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 402.66 g/mol
• Formule: C₂₆H₄₆N₂O
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder